Skip to Main Content

Paper Details

CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Oncoimmunology
18
2021
CCL5, CCL5 receptors, CD8, EGFR, KRAS, KRAS mutations, KRAS-mutant lung cancer, MAPK, cancer, cancer cells, driver oncogenes, immune suppressive cells, immunosuppressive regulatory T cells, lung adenocarcinoma, lung cancer, lung cancer cells, lung tumor, mice, oncogenic EGFR, patients, regulatory T cells, syngeneic KRAS-mutant lung cancer cells, tumor, tumor-cell
Author NameAffiliation
Mark RaffeldCenter for Cancer Research, National Cancer Institute
Mark RaffeldCenter for Cancer Research, National Cancer Institute
Wan L LamBC Cancer Research Institute
Wan L LamUniversity of British Columbia
Wan L LamUniversity of British Columbia
  • 1 - 5

Datasets

Release 1.2